SETD7 and prostate cancer: The dysfunction of SET7 is involved in the pathogenesis of several diseases including alopecia areata, breast cancer, tumor and cancer progression, atherosclerosis in human carotid plaques, chronic renal diseases, diabetes, obesity, ovarian cancer, prostate cancer, hepatocellular carcinoma, and pulmonary fibrosis.